http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 10 Apr 2024 16:02:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Elicio+Therapeutics%2C+++++++++++++++++++Filed+by%3A+Clal+Biotechnology+Industries+Ltd./23051816.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Elicio+Therapeutics%2C+++++++++++++++++++Filed+by%3A+Clal+Biotechnology+Industries+Ltd./23051816.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Elicio+Therapeutics%2C+++++++++++++++++++Filed+by%3A+Clal+Biotechnology+Industries+Ltd./23051816.html Wed, 10 Apr 2024 16:02:00 -0400 ANGN O.49822165 http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Elicio+Therapeutics%2C+++++++++++++++++++Filed+by%3A+Clal+Biotechnology+Industries+Ltd./23051816.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Elicio+Therapeutics%2C+++++++++++++++++++Filed+by%3A+Clal+Biotechnology+Industries+Ltd./23051816.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++SC+13DA+++Elicio+Therapeutics%2C+++++++++++++++++++Filed+by%3A+Clal+Biotechnology+Industries+Ltd./23051816.html Wed, 10 Apr 2024 16:02:00 -0400 ANGN O.49822165 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Elicio+Therapeutics%2C++++++For%3A+Apr+05/23035491.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Elicio+Therapeutics%2C++++++For%3A+Apr+05/23035491.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Elicio+Therapeutics%2C++++++For%3A+Apr+05/23035491.html Fri, 05 Apr 2024 16:34:00 -0400 ANGN O.49822165 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Elicio+Therapeutics%2C++++++For%3A+Apr+05/23035491.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Elicio+Therapeutics%2C++++++For%3A+Apr+05/23035491.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Elicio+Therapeutics%2C++++++For%3A+Apr+05/23035491.html Fri, 05 Apr 2024 16:34:00 -0400 ANGN O.49822165 http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html for the full story. http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Fri, 05 Apr 2024 16:30:00 -0400 A.35552990 ANGN ELTX O.00074346 O.49822165 http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html for the full story. http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Fri, 05 Apr 2024 16:30:00 -0400 A.35552990 ANGN ELTX O.00074346 O.49822165 http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html for the full story. http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Fri, 05 Apr 2024 16:30:00 -0400 A.35552990 ANGN ELTX O.00074346 O.49822165 http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html for the full story. http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Fri, 05 Apr 2024 16:30:00 -0400 A.35552990 ANGN ELTX O.00074346 O.49822165 http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html for the full story. http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Fri, 05 Apr 2024 16:30:00 -0400 A.35552990 ANGN ELTX O.00074346 O.49822165 http://www.streetinsider.com/Globe+Newswire/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html for the full story. http://www.streetinsider.com/Globe+Newswire/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Fri, 05 Apr 2024 16:30:00 -0400 A.35552990 ANGN ELTX O.00074346 O.49822165 http://www.streetinsider.com/Globe+Newswire/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html for the full story. http://www.streetinsider.com/Globe+Newswire/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Fri, 05 Apr 2024 16:30:00 -0400 A.35552990 ANGN ELTX O.00074346 O.49822165 http://www.streetinsider.com/Globe+Newswire/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html for the full story. http://www.streetinsider.com/Globe+Newswire/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Fri, 05 Apr 2024 16:30:00 -0400 A.35552990 ANGN ELTX O.00074346 O.49822165 http://www.streetinsider.com/Globe+Newswire/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html for the full story. http://www.streetinsider.com/Globe+Newswire/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Fri, 05 Apr 2024 16:30:00 -0400 A.35552990 ANGN ELTX O.00074346 O.49822165 http://www.streetinsider.com/Globe+Newswire/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html for the full story. http://www.streetinsider.com/Globe+Newswire/Elicio+Therapeutics+to+Present+Updated+Clinical+T+Cell+and+Antigen+Spreading+Response+Data+from+the+Ongoing+AMPLIFY-201+Phase+1+Study+of+ELI-002+and+Preclinical+Data+on+ELI-007+and+ELI-008+at+the+AACR/23035390.html Fri, 05 Apr 2024 16:30:00 -0400 A.35552990 ANGN ELTX O.00074346 O.49822165 http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Elicio+Therapeutics%2C+++++++++++++++++/23001022.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Elicio+Therapeutics%2C+++++++++++++++++/23001022.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Elicio+Therapeutics%2C+++++++++++++++++/23001022.html Fri, 29 Mar 2024 15:29:00 -0400 ANGN O.49822165 http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Elicio+Therapeutics%2C+++++++++++++++++/23001022.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Elicio+Therapeutics%2C+++++++++++++++++/23001022.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Elicio+Therapeutics%2C+++++++++++++++++/23001022.html Fri, 29 Mar 2024 15:29:00 -0400 ANGN O.49822165 http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Elicio+Therapeutics%2C+++++++++++++++++/23001017.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Elicio+Therapeutics%2C+++++++++++++++++/23001017.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Elicio+Therapeutics%2C+++++++++++++++++/23001017.html Fri, 29 Mar 2024 15:27:00 -0400 ANGN O.49822165 http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Elicio+Therapeutics%2C+++++++++++++++++/23001017.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Elicio+Therapeutics%2C+++++++++++++++++/23001017.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++Elicio+Therapeutics%2C+++++++++++++++++/23001017.html Fri, 29 Mar 2024 15:27:00 -0400 ANGN O.49822165 http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Elicio+Therapeutics%2C++++++For%3A+Dec+31/23000682.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Elicio+Therapeutics%2C++++++For%3A+Dec+31/23000682.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Elicio+Therapeutics%2C++++++For%3A+Dec+31/23000682.html Fri, 29 Mar 2024 14:00:00 -0400 ANGN O.49822165 http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Elicio+Therapeutics%2C++++++For%3A+Dec+31/23000682.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Elicio+Therapeutics%2C++++++For%3A+Dec+31/23000682.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Elicio+Therapeutics%2C++++++For%3A+Dec+31/23000682.html Fri, 29 Mar 2024 14:00:00 -0400 ANGN O.49822165 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Elicio+Therapeutics%2C++++++For%3A+Mar+29/22999294.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Elicio+Therapeutics%2C++++++For%3A+Mar+29/22999294.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Elicio+Therapeutics%2C++++++For%3A+Mar+29/22999294.html Fri, 29 Mar 2024 08:36:00 -0400 ANGN O.49822165 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Elicio+Therapeutics%2C++++++For%3A+Mar+29/22999294.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Elicio+Therapeutics%2C++++++For%3A+Mar+29/22999294.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Elicio+Therapeutics%2C++++++For%3A+Mar+29/22999294.html Fri, 29 Mar 2024 08:36:00 -0400 ANGN O.49822165 http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+Reports+2023+Financial+Results+and+Provides+Corporate+Updates/22999266.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+Reports+2023+Financial+Results+and+Provides+Corporate+Updates/22999266.html for the full story. http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+Reports+2023+Financial+Results+and+Provides+Corporate+Updates/22999266.html Fri, 29 Mar 2024 08:30:00 -0400 A.03350906 ANGN ELTX O.01868273 O.49822165 http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+Reports+2023+Financial+Results+and+Provides+Corporate+Updates/22999266.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+Reports+2023+Financial+Results+and+Provides+Corporate+Updates/22999266.html for the full story. http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+Reports+2023+Financial+Results+and+Provides+Corporate+Updates/22999266.html Fri, 29 Mar 2024 08:30:00 -0400 A.03350906 ANGN ELTX O.01868273 O.49822165 http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+Reports+2023+Financial+Results+and+Provides+Corporate+Updates/22999266.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+Reports+2023+Financial+Results+and+Provides+Corporate+Updates/22999266.html for the full story. http://www.streetinsider.com/Press+Releases/Elicio+Therapeutics+Reports+2023+Financial+Results+and+Provides+Corporate+Updates/22999266.html Fri, 29 Mar 2024 08:30:00 -0400 A.03350906 ANGN ELTX O.01868273 O.49822165